(Q39472920)

English

In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori

scientific article published on February 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori (English)

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Helicobacter pylori

0 references

author name string

Y Kawakami

1

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

T Akahane

2

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

M Yamaguchi

3

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

K Oana

4

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Y Takahashi

5

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Y Okimura

6

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

T Okabe

7

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

A Gotoh

8

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

T Katsuyama

9

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

44

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

458-461

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

12 September 2017

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

12 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

21 August 2018

Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

12 September 2017

Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

25 September 2017

Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

25 September 2017

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

17 June 2018

Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

17 June 2018

Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

21 August 2018

Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89707

21 August 2018

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori: current status

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of Lansoprazole in Eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful development of air-dried microplates (HP-Plates) for susceptibility testing against Helicobacter pylori isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/10639386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.44.2.458-461.2000

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39472920&oldid=1829816647"